Status and phase
Conditions
Treatments
About
The purpose of this study is to compare if the combination of valsartan 320 mg/lisinopril 20 mg versus the monotherapies of lisinopril 40 mg or valsartan 320 mg will result in a greater decrease of urinary albumin excretion measured as urinary albumin/creatinine ratio (UACR) in the first morning urine of hypertensive subjects with previously diagnosed microalbuminuria (MAU).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Evidence of renal impairment as determined by any one of the following:
Serum potassium values <3.5 mmol/l or >5.5 mmol/l at Visit 1
Any medical condition which might significantly alter the urinary excretion of albumin
Other protocol-defined exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal